Report ID: SQSG35H2019
Report ID:
SQSG35H2019 |
Region:
Global |
Published Date: April, 2024
Pages:
157
|
Tables:
120 |
Figures:
77
Biopharmaceuticals Contract Manufacturing Market Drivers
Continuously rising generics demand, rising research & developments activities, and growing investments in advanced technologies are major factors expected to drive the growth of the global biopharmaceuticals market over the forecast period. Moreover, increasing demand for biological therapies and expansion in nuclear medicine sector coupled with the higher emphasis on specialty medicines are some others factors projected to have a positive impact on the global market over the coming years.
Biopharmaceuticals Contract Manufacturing Market Restraint
Various issues associated with the biopharmaceutical manufacturing process such as labelling issues, packaging issues, and sterilization problems are expected to be the major restraining factors for the growth of the global biopharmaceuticals contract manufacturing market during the forecast period. Additionally, lack of consumer trust and process knowledge are also likely to hamper the market growth in the coming years.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONBiopharmaceuticals Contract Manufacturing Market size was valued at USD 17 billion in 2019 and is poised to grow from USD 17.88 billion in 2023 to USD 28.22 billion by 2031, growing at a CAGR of 5.2% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQSG35H2019